@fordham1

Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial

, , , , , , , and . Research Square, (February 2022)
DOI: 10.21203/rs.3.rs-1290999/v1

Description

Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial | Research Square

Links and resources

Tags